ORPHA:95431
Twin to twin transfusion syndrome
Also known as: Feto-fetal transfusion syndrome
Publications
4,207
Trials
12
Interventional, condition-specific
Researchers
1,008
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
Twin twin transfusion syndrome (TTTS) is a rare condition seen in twin monochorionic pregnancies, typically developing during the 15-26 week gestation period and usually due to unbalanced intertwin placental anastomoses, where an unequal exchange of blood between twins causes oligohydramnios in one sac and polyhydramnios in the other which can lead to a high perinatal mortality rate and a high rate of disability in survivors if left untreated
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019805
- MeSH:D005330
- UMLS:C2909036
- NCIT:C113824
Additional Mondo synonyms (7)
Twin Anemia Polycythemia Sequence · Twin-Twin transfusion syndrome · foetal blood loss from foetal haemorrhage into co-twin · foetal haemorrhage into co-twin · placental transfusion syndrome · stuck Twin syndrome · twin-to-twin transfusion syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
4,207 matched papers (2,223 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
12 matched on ClinicalTrials.gov (5 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
4,207
4,207 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
4,207 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
2,223 in the last 10 years · low confidence
Phrase hits: 4,204 · MeSH hits: 17
Who's working on it?
1,008
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Khalil A15 papers · 2026
Fetal Medicine Unit, Saint George's Hospital, University of London, London, United Kingdom.
Papers in Europe PMC - 02Slaghekke F12 papers · 2026
Department of Obstetrics, Division of Fetal Therapy, Leiden University Medical Center, Leiden, the Netherlands.
Papers in Europe PMC - 03Lopriore E11 papers · 2026
Department of Pediatrics, Division of Neonatology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands.
Papers in Europe PMC - 04D'Antonio F8 papers · 2026
Center for Fetal Care and High-Risk Pregnancy, University of Chieti, Chieti, Italy (D'Antonio).
Papers in Europe PMC - 05de Vries LS7 papers · 2026
Department of Neonatology, University Medical Center Utrecht, Utrecht, the Netherlands.
Papers in Europe PMC - 06Mustafa HJ7 papers · 2026
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Papers in Europe PMC - 07Tollenaar LSA7 papers · 2026
Department of Obstetrics, Division of Fetal Therapy, Leiden University Medical Center, Leiden, the Netherlands.
Papers in Europe PMC - 08Baschat AA6 papers · 2026
Johns Hopkins Center for Fetal Therapy, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Papers in Europe PMC - 09Belfort MA6 papers · 2026
Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Papers in Europe PMC - 10Espinoza J6 papers · 2026
Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
12
interventional trials for this specific condition
12 interventional trials matched this specific condition name; 5 currently recruiting in our sample.
Data as of 11 September 2026
12 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 93.2th percentile).
low confidence · 93.2th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
12 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06056635·RECRUITING·A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures
Not reviewed·Conditions: Fetal Conditions · Maternal; Procedure · Pregnancy Related · Twin to Twin Transfusion Syndrome·Matched via name phrase
- NCT07667647·NOT YET RECRUITING·MoDi Twin Placental Imaging
Not reviewed·Conditions: Monochorionic Diamniotic Placenta · Monochorial Monoamniotic Placenta · Monochorionic Twins · Ultrasound Doppler·Matched via name phrase
- NCT06084247·NOT YET RECRUITING·The Efficacy of the KARL STORZ Curved Fetoscope and Straight Fetoscope for Laser Photocoagulation of Placental Anastomoses
Not reviewed·Conditions: Twin to Twin Transfusion Syndrome·Matched via name phrase
- NCT06829901·RECRUITING·The Effect of Uterine Entry In Fetoscopic Laser Photocoagulation for Twin-To-Twin Transfusion Syndrome
Not reviewed·Conditions: Twin to Twin Transfusion·Matched via name phrase
- NCT06991400·RECRUITING·Evaluation of Laparotomy With Trans-Amniotic Suture Placement in TTTS Surgery
Not reviewed·Conditions: Twin to Twin Transfusion Syndrome · Twin Anemia-Polycythemia Sequence·Matched via name phrase
Observational and natural-history studies
12 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT05008744·RECRUITING·Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome
Not reviewed·Conditions: Twin to Twin Transfusion as Antepartum Condition · Monochorionic Diamniotic Placenta·Matched via name phrase
- NCT03775954·RECRUITING·Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Not reviewed·Conditions: High Risk Pregnancy · Congenital Heart Disease · Fetal Hydrops · Twin Monochorionic Monoamniotic Placenta·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 10 · after dedupe 10 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 10 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (10)
- isrctn·ISRCTN16879394·No longer recruiting·FERN: Intervention or expectant management for early onset selective fetal growth restriction in monochorionic twin pregnancy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN86684235·Recruiting·Use of aspirin for the prevention of preeclampsia in twin pregnancies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN33458649·No longer recruiting·Developing a non-invasive treatment for twin-twin transfusion syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13114861·No longer recruiting·The optimal management in monochorionic twins (OMMIT) study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN92719670·No longer recruiting·Clamping the umbilical cord in premature deliveries (CUPID)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66445401·No longer recruiting·Prevention of preterm birth in twin pregnancies - “Randomised trial of progesterone versus placebo”
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98835694·No longer recruiting·A randomised trial in women with a twin pregnancy, using the Arabin pessary to prevent preterm birth – STOPPIT-2
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN21456601·No longer recruiting·Cord Pilot Trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN01096902·No longer recruiting·Randomised study of pessary vs standard management in women with increased chance of premature birth
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN40512715·No longer recruiting·17-Alpha hydroxyprogesterone in Multiple pregnancies to Prevent Handicapped InfAnts
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Twin to twin transfusion syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Twin to twin transfusion syndrome" OR "Feto-fetal transfusion syndrome" OR "Twin Anemia Polycythemia Sequence" OR "Twin-Twin transfusion syndrome" OR "foetal blood loss from foetal haemorrhage into co-twin" OR "foetal haemorrhage into co-twin" OR "placental transfusion syndrome" OR "stuck Twin syndrome" OR "twin-to-twin transfusion syndrome"
MeSH descriptor terms unioned into the query: Fetofetal Transfusion
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Twin to twin transfusion syndrome" OR "Feto-fetal transfusion syndrome" OR "Twin Anemia Polycythemia Sequence" OR "Twin-Twin transfusion syndrome" OR "foetal blood loss from foetal haemorrhage into co-twin" OR "foetal haemorrhage into co-twin" OR "placental transfusion syndrome" OR "stuck Twin syndrome" OR "twin-to-twin transfusion syndrome" OR "Fetofetal Transfusion"
Interventional trials matched via: phrase, mesh (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 12 interventional · 12 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (4207) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T04:42:44.179Z
